156 related articles for article (PubMed ID: 12725603)
1. Triple therapy for 7 days vs. triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacter pylori infection. A double blind placebo controlled trial.
Marzio L; Cellini L; Angelucci D
Dig Liver Dis; 2003 Jan; 35(1):20-3. PubMed ID: 12725603
[TBL] [Abstract][Full Text] [Related]
2. Cure of Helicobacter pylori-positive active duodenal ulcer patients: a double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy. GISU (Interdisciplinary Group for Ulcer Study).
Di Mario F; Battaglia F; Dal Bò N; Leandro G; Benedetti E; Bottona E; Caroli A; Costan-Biedo F; De Bastiani R; Germanà B; Andrea Grassi S; Madia D; Marcon V; Marin R; Monica F; Olivieri P; Orzes N; Pilotto A; Ronzani G; Saggioro A; Tafner G
Dig Liver Dis; 2000 Mar; 32(2):108-15. PubMed ID: 10975783
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer.
O'Morain C; Dettmer A; Rambow A; von Fritsch E; Fraser AG
Helicobacter; 1996 Sep; 1(3):130-7. PubMed ID: 9398893
[TBL] [Abstract][Full Text] [Related]
4. One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease.
Tulassay Z; Kryszewski A; Dite P; Kleczkowski D; Rudzinski J; Bartuzi Z; Hasselgren G; Larkö A; Wrangstadh M
Eur J Gastroenterol Hepatol; 2001 Dec; 13(12):1457-65. PubMed ID: 11742194
[TBL] [Abstract][Full Text] [Related]
5. Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group.
Wurzer H; Rodrigo L; Stamler D; Archambault A; Rokkas T; Skandalis N; Fedorak R; Bazzoli F; Hentschel E; Mora P; Archimandritis A; Megraud F
Aliment Pharmacol Ther; 1997 Oct; 11(5):943-52. PubMed ID: 9354205
[TBL] [Abstract][Full Text] [Related]
6. Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study.
Luzza F; Giglio A; Ciliberto E; Belmonte A; Cavaliere C; Saccà N; Frandina C; Fiocca R; Trimboli V; Pallone F
Clin Ther; 2001 May; 23(5):761-70. PubMed ID: 11394734
[TBL] [Abstract][Full Text] [Related]
7. One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.
Tzivras M; Archimandritis A; Balatsos V; Delis V; Souyioultzis S; Skandalis N; Kanellopoulou E; Manika Z; Davaris P
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1185-9. PubMed ID: 9471024
[TBL] [Abstract][Full Text] [Related]
8. One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients.
Moshkowitz M; Konikoff FM; Peled Y; Brill S; Hallak A; Tiomny E; Santo M; Bujanover Y; Gilat T
Aliment Pharmacol Ther; 1996 Dec; 10(6):1015-9. PubMed ID: 8971304
[TBL] [Abstract][Full Text] [Related]
9. Omeprazole versus ranitidine: short-term triple-therapy in patients with Helicobacter pylori-positive duodenal ulcers.
Spadaccini A; De Fanis C; Sciampa G; Masciulli V; Pantaleone U; Di Virgilio M; Magnarini C; Pizzicannella G
Aliment Pharmacol Ther; 1996 Oct; 10(5):829-31. PubMed ID: 8899094
[TBL] [Abstract][Full Text] [Related]
10. High effectiveness and safety of one-week antibiotic regimen in Helicobacter pylori eradication.
Dalla Libera M; Pazzi P; Carli G; Gamberini S; Scagliarini R; Merighi A; Gullini S
Aliment Pharmacol Ther; 1996 Apr; 10(2):203-6. PubMed ID: 8730251
[TBL] [Abstract][Full Text] [Related]
11. Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies: results of a randomized, double-blind, multicenter trial. Gastrointestinal Utilization Trial Study Group.
Sonnenberg A; Schwartz JS; Cutler AF; Vakil N; Bloom BS
Arch Intern Med; 1998 Apr; 158(8):852-60. PubMed ID: 9570170
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of omeprazole plus two antimicrobials for the eradication of Helicobacter pylori in a Turkish population.
Uygun A; Ates Y; Erdil A; Kadayifci A; Cetin C; Gulsen M; Karaeren N; Dagalp K
Clin Ther; 1999 Sep; 21(9):1539-48. PubMed ID: 10509849
[TBL] [Abstract][Full Text] [Related]
13. Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection.
Kolkman JJ; Tan TG; Oudkerk Pool M; Van Kleef WA; Geraedts AA; Timmerman RJ; Crobach LF; Nicolai JJ; Wolff AA; Van Der Laan J
Aliment Pharmacol Ther; 1997 Dec; 11(6):1123-9. PubMed ID: 9663840
[TBL] [Abstract][Full Text] [Related]
14. One week triple therapy for Helicobacter pylori: does high-dose clarithromycin confer additional benefit?
O'Connor HJ; Loane J; Bindel H; Bhutta AS; Cunnane K
Helicobacter; 1997 Dec; 2(4):199-204. PubMed ID: 9421124
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradication.
Choi IJ; Jung HC; Choi KW; Kim JH; Ahn DS; Yang US; Rew JS; Lee SI; Rhee JC; Chung IS; Chung JM; Hong WS
Aliment Pharmacol Ther; 2002 Jan; 16(1):145-51. PubMed ID: 11856089
[TBL] [Abstract][Full Text] [Related]
16. Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study.
Wong BC; Lam SK; Lai KC; Hu WH; Ching CK; Ho J; Yuen ST; Chan CK; Lau GK; Lai CL
Aliment Pharmacol Ther; 1999 Mar; 13(3):303-9. PubMed ID: 10102962
[TBL] [Abstract][Full Text] [Related]
17. The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy.
Zanten SJ; Bradette M; Farley A; Leddin D; Lind T; Unge P; Bayerdörffer E; Spiller RC; O'Morain C; Sipponen P; Wrangstadh M; Zeijlon L; Sinclair P
Aliment Pharmacol Ther; 1999 Mar; 13(3):289-95. PubMed ID: 10102960
[TBL] [Abstract][Full Text] [Related]
18. Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
Wong BC; Xiao SD; Hu FL; Qian SC; Huang NX; Li YY; Hu PJ; Daldiyono ; Manan C; Lesmana L; Carpio RE; Perez JY; Fock KM; Kachintorn U; Phornphutkul K; Kullavanijaya P; Ho J; Lam SK
Aliment Pharmacol Ther; 2000 Feb; 14(2):217-24. PubMed ID: 10651663
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
[TBL] [Abstract][Full Text] [Related]
20. Comparative treatment of Helicobacter pylori-positive duodenal ulcer using pantoprazole at low and high doses versus omeprazole in triple therapy.
Catalano F; Branciforte G; Catanzaro R; Bentivegna C; Cipolla R; Nuciforo G; Brogna A
Helicobacter; 1999 Sep; 4(3):178-84. PubMed ID: 10469192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
